Patrick S. Donahue, MD, PhD

Improving Emergency Department Boarding Time: Balancing Efficiency and Safety. Vukovic, AA; Purcell, T; Thomas, S; Recto, MA; Donahue, PS; Fatten, M; Bartlett, S; Thorne, A; Demeritt, B; Ballinger, J; Hawkins, D; White, CM; Statile, AM; Marshall, TL. Pediatrics. 2026; 157(1).

Engineered Feedback Employing Natural Hypoxia-Responsive Factors Enhances Synthetic Hypoxia Biosensors. Dreyer, KS; Donahue, PS; Boucher, JD; Chambers, KM; Ornelas, MY; Edelstein, HI; Leibowitz, BD; Zhu, KJ; Dray, KE; Muldoon, JJ; Leonard, JN. ACS Synthetic Biology. 2025; 14(5):1464-1481.

Comparative Evaluation of Synthetic Cytokines for Enhancing Production and Performance of NK92 Cell-Based Therapies. Deol, S; Donahue, PS; Mitrut, RE; Hammitt-Kess, IJ; Ahn, J; Zhang, B; Leonard, JN. GEN Biotechnol. 2023; 2(3):228-246.

Model-guided design of mammalian genetic programs. Muldoon, JJ; Kandula, V; Hong, M; Donahue, PS; Boucher, JD; Bagheri, N; Leonard, JN. Science Advances. 2021; 7(8).

The COMET toolkit for composing customizable genetic programs in mammalian cells. Donahue, PS; Draut, JW; Muldoon, JJ; Edelstein, HI; Bagheri, N; Leonard, JN. Nature Communications. 2020; 11(1):779.

Elucidation and refinement of synthetic receptor mechanisms. Edelstein, HI; Donahue, PS; Muldoon, JJ; Kang, AK; Dolberg, TB; Battaglia, LM; Allchin, ER; Hong, M; Leonard, JN. Synthetic Biology. 2020; 5(1):ysaa017.

Synthetic biology: Reframing cell therapy for cancer. Dolberg, TB; Donahue, PS; Leonard, JN. Nature Chemical Biology. 2018; 14(3):204-205.

Building with intent: technologies and principles for engineering mammalian cell-based therapies to sense and respond. Muldoon, JJ; Donahue, PS; Dolberg, TB; Leonard, JN. Current Opinion in Biomedical Engineering. 2017; 4:127-133.

Thermodynamic signature of DNA damage: characterization of DNA with a 5-hydroxy-2'-deoxycytidine·2'-deoxyguanosine base pair. Ganguly, M; Szulik, MW; Donahue, PS; Clancy, K; Stone, MP; Gold, B. Biochemistry. 2012; 51(9):2018-2027.